Peptron, Inc. (KOSDAQ:087010)
South Korea · Delayed Price · Currency is KRW 286,000
+34,000 (13.49%)
Nov 7, 2025, 3:30 PM KST
Peptron Revenue
Peptron had revenue of 1.43B KRW in the quarter ending June 30, 2025, with 163.05% growth. This brings the company's revenue in the last twelve months to 5.18B, up 106.96% year-over-year. In the year 2024, Peptron had annual revenue of 3.15B, down -5.68%.
Revenue (ttm)
5.18B
Revenue Growth
+106.96%
P/S Ratio
1,287.70
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.67T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.15B | -189.71M | -5.68% |
| Dec 31, 2023 | 3.34B | -2.47B | -42.52% |
| Dec 31, 2022 | 5.81B | -810.52M | -12.24% |
| Dec 31, 2021 | 6.62B | 3.50B | 112.28% |
| Dec 31, 2020 | 3.12B | 1.32B | 73.26% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5.03T |
| Celltrion | 3.75T |
| Yuhan | 2.17T |
| Hanmi Pharm. | 1.50T |
| SK Biopharmaceuticals | 620.28B |
| PharmaResearch | 449.81B |
| Sam Chun Dang Pharm. | 215.10B |
| ALTEOGEN | 158.06B |